NCT03744078

Brief Summary

This study evaluates the addition of transcervical Foley catheter balloon and vaginal prostaglandin E2 induction in premature rupture of membranes. Half of participants will be used combine transcervical Foley catheter balloon and vaginal prostaglandin E2, while the other half will be used alone vaginal prostaglandin E2.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 27, 2018

Completed
19 days until next milestone

Study Start

First participant enrolled

April 15, 2018

Completed
7 months until next milestone

First Posted

Study publicly available on registry

November 16, 2018

Completed
29 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2018

Completed
17 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2019

Completed
Last Updated

November 16, 2018

Status Verified

November 1, 2018

Enrollment Period

8 months

First QC Date

March 27, 2018

Last Update Submit

November 14, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • induction-to- delivery time

    the length of time between the beginning of induction and the end of labor

    an average of one year

Secondary Outcomes (5)

  • tachysystole

    an average of one year

  • chorioamnionitis

    an average of one year

  • postpartum hemorrhage

    an average of one year

  • neonatal outcome

    an average of one year

  • admission to neonatal intensive care unit

    an average of one year

Study Arms (2)

PGE2 with Foley balloon catheter

ACTIVE COMPARATOR

10 mg PGE2 vaginal ovul will be inserted to the posterior fornix and an 18-F Foley catheter which filling with 60 mL of saline solution will be placed into the cervix

Device: Foley balloon catheter

PGE2 vaginal ovule

NO INTERVENTION

10 mg PGE2 vaginal ovule will be inserted to the posterior fornix

Interventions

18-F Foley catheter which filling with 60 mL of saline solution will be placed into the cervix

PGE2 with Foley balloon catheter

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailspregnant women
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • singleton pregnancy,
  • gestational age ≥34 weeks,
  • rupture of membranes,
  • cephalic presentation,
  • bishop score ≤5,
  • had less than three uterine contractions in every 10 minutes.

You may not qualify if:

  • Patients who had contraindications for vaginal delivery,
  • previous uterine surgery,
  • fetal malpresentation,
  • multifetal pregnancy,
  • more than three contractions in 10 minutes,
  • contraindications to prostaglandins,
  • a category II or III fetal heart rate pattern,
  • anomalous fetus,
  • fetal demise
  • women with immediate delivery indications -

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Doga

Istanbul, Kucukcekmece, 34303, Turkey (Türkiye)

RECRUITING

Zeynep Kamil Education and Research Hospital

Istanbul, Uskudar, 34668, Turkey (Türkiye)

RECRUITING

Related Publications (1)

  • de Vaan MD, Ten Eikelder ML, Jozwiak M, Palmer KR, Davies-Tuck M, Bloemenkamp KW, Mol BWJ, Boulvain M. Mechanical methods for induction of labour. Cochrane Database Syst Rev. 2023 Mar 30;3(3):CD001233. doi: 10.1002/14651858.CD001233.pub4.

MeSH Terms

Conditions

Fetal Membranes, Premature Rupture

Condition Hierarchy (Ancestors)

Obstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • ahmet eser

    Zeynep Kamil Maternity and Children's Training and Research Hospital, Department of Obstetrics and Gynecology, Istanbul, Turkey

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D.

Study Record Dates

First Submitted

March 27, 2018

First Posted

November 16, 2018

Study Start

April 15, 2018

Primary Completion

December 15, 2018

Study Completion

January 1, 2019

Last Updated

November 16, 2018

Record last verified: 2018-11

Locations